Arch Therapeutics, Inc. (ARTH)
OTCMKTS: ARTH · Delayed Price · USD
1.180
+0.040 (3.51%)
Apr 24, 2024, 1:58 PM EDT - Market closed

Arch Therapeutics Statistics

Total Valuation

ARTH has a market cap or net worth of $5.60 million. The enterprise value is $12.67 million.

Market Cap 5.60M
Enterprise Value 12.67M

Important Dates

Earnings Date n/a
Ex-Dividend Date n/a

Share Statistics

ARTH has 4.74 million shares outstanding. The number of shares has increased by 276.77% in one year.

Shares Outstanding 4.74M
Shares Change (YoY) +276.77%
Shares Change (QoQ) +0.38%
Owned by Insiders (%) 25.13%
Owned by Institutions (%) 25.30%
Float 2.81M

Valuation Ratios

PE Ratio n/a
Forward PE 0.08
PS Ratio 48.52
Forward PS n/a
PB Ratio n/a
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 109.88
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 0.16

Current Ratio 0.16
Quick Ratio n/a
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -2.27

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) -437.81%
Return on Capital (ROIC) n/a
Revenue Per Employee $14,416
Profits Per Employee -$997,077
Employee Count 8
Asset Turnover 0.06
Inventory Turnover 0.06

Taxes

Income Tax -1.38M
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -60.67% in the last 52 weeks. The beta is 3.56, so ARTH's price volatility has been higher than the market average.

Beta (1Y) 3.56
52-Week Price Change -60.67%
50-Day Moving Average 1.93
200-Day Moving Average 2.73
Relative Strength Index (RSI) 33.77
Average Volume (30 Days) 4,229

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, ARTH had revenue of $115,331 and -$7.98 million in losses. Loss per share was -$3.31.

Revenue 115,331
Gross Profit 31,197
Operating Income -5.26M
Pretax Income -7.86M
Net Income -7.98M
EBITDA -5.26M
EBIT -5.26M
Loss Per Share -$3.31
Full Income Statement

Balance Sheet

The company has $205,850 in cash and $7.28 million in debt, giving a net cash position of -$7.08 million or -$1.49 per share.

Cash & Cash Equivalents 205,850
Total Debt 7.28M
Net Cash -7.08M
Net Cash Per Share -$1.49
Equity / Book Value -9.58M
Book Value Per Share -2.02
Working Capital -9.58M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$3.59 million and capital expenditures -$4,521, giving a free cash flow of -$3.59 million.

Operating Cash Flow -3.59M
Capital Expenditures -4,521
Free Cash Flow -3.59M
FCF Per Share -$0.76
Full Cash Flow Statement

Margins

Gross margin is 27.05%, with operating and profit margins of -4,563.74% and -6,916.28%.

Gross Margin 27.05%
Operating Margin -4,563.74%
Pretax Margin -6,819.01%
Profit Margin -6,916.28%
EBITDA Margin -4,562.05%
EBIT Margin -4,563.74%
FCF Margin -3,113.89%

Dividends & Yields

ARTH does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -276.77%
Shareholder Yield -276.77%
Earnings Yield -142.54%
FCF Yield -64.18%

Analyst Forecast

Price Target n/a
Price Target Difference n/a
Analyst Consensus n/a
Analyst Count n/a
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a

Stock Splits

The last stock split was on January 18, 2023. It was a reverse split with a ratio of 1:200.

Last Split Date Jan 18, 2023
Split Type Reverse
Split Ratio 1:200

Scores

ARTH has an Altman Z-Score of -65.23 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -65.23
Piotroski F-Score 3